ALS
Clinical trials for ALS explained in plain language.
Never miss a new study
Get alerted when new ALS trials appear
Sign up with your email to follow new studies for ALS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
ALS drug trial halted: oral Edaravone's promise unfulfilled
Disease control TerminatedThis study tested an oral form of edaravone in 384 adults with ALS to see if it could slow the disease's progression over 48 weeks. Participants were randomly assigned to different dosing schedules. The trial was terminated early, and results are not yet fully available.
Matched conditions: ALS
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
ALS drug trial halted early: what we know about oral edaravone
Disease control TerminatedThis study tested two doses of oral edaravone in 202 people with ALS to see if it could slow disease progression. Participants were followed for up to 48 weeks. The trial was terminated early, so the full results are not available.
Matched conditions: ALS
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a helper make video doctor visits better for ALS patients?
Knowledge-focused TerminatedThis study looked at how satisfied people with ALS (Lou Gehrig's disease) were when they had doctor visits by video from home, with a nurse or physiotherapist there to help. About 38 patients who used a breathing machine at home took part. The goal was to see if this kind of care…
Matched conditions: ALS
Phase: NA • Sponsor: AGIR à Dom • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC